Jinxin Fertility Group Limited

HKSE 1951.HK

Jinxin Fertility Group Limited Cash and Short-Term Investments for the year ending December 31, 2023: USD 120.13 M

Jinxin Fertility Group Limited Cash and Short-Term Investments is USD 120.13 M for the year ending December 31, 2023, a -40.84% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Jinxin Fertility Group Limited Cash and Short-Term Investments for the year ending December 31, 2022 was USD 203.05 M, a -33.08% change year over year.
Jinxin Fertility Group Limited Cash and Short-Term Investments for the year ending December 31, 2021 was USD 303.43 M, a -19.79% change year over year.
Jinxin Fertility Group Limited Cash and Short-Term Investments for the year ending December 31, 2020 was USD 378.28 M, a -20.08% change year over year.
Jinxin Fertility Group Limited Cash and Short-Term Investments for the year ending December 31, 2019 was USD 473.32 M, a 156.49% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

HKSE: 1951.HK

Jinxin Fertility Group Limited

CEO	Mr. Yang Dong
IPO Date	June 25, 2019
Location	China
Headquarters	No. 301, North Jingsha Road
Employees	3,779
Sector	Finance
Industries Investment Banking & Asset Management Biotechnology Dental Care Hedge Funds Hospitals & Clinics Professional Services Research & Consulting Venture Capital

Description

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

Key trends

Past 5 years